Found: 1
Select item for more details and to access through your institution.
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 641, p. 1, doi. 10.1126/scitranslmed.abm6420
- By:
- Publication type:
- Article